Importantly, altered HH signaling as well as the ectopic activation of its effectors, GLI transcription factors, are implicated in multiple types of cancers, most notably in basal cell carcinoma (BCC), medulloblastoma (MB), and rhabdomyosarcoma (reviewed in [1]). The gene discussed is GLI1; the disease is rhabdomyosarcoma.